
DexCom DXCM
$ 60.36
1.48%
Quarterly report 2026-Q1
added 04-30-2026
DexCom Operating Cycle 2011-2026 | DXCM
Annual Operating Cycle DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 216 | 204 | 195 | 211 | 168 | 151 | 150 | 141 | 150 | 171 | 130 | 114 | 122 | 134 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 216 | 114 | 164 |
Quarterly Operating Cycle DexCom
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 225 | - | 207 | 205 | - | 221 | 227 | 243 | - | 191 | 183 | 193 | - | 85 | 99 | 215 | - | 222 | 227 | 227 | - | 212 | 214 | 189 | 56.5 | 139 | 162 | 161 | 61.2 | 143 | 158 | 170 | 55.5 | 66.4 | 71.8 | 75.7 | 54.2 | 62.5 | 67.6 | 69 | 51.7 | 170 | 191 | 162 | 22.9 | 67 | 77.2 | 91.2 | 23 | 53.7 | 59.1 | 87.2 | 26.7 | 45.9 | 55.4 | 94.9 | 25.5 | 73.9 | 78.1 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 243 | 22.9 | 125 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Myriad Genetics
MYGN
|
95.1 | $ 4.11 | -18.29 % | $ 381 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.86 | -4.7 % | $ 400 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.23 | 2.95 % | $ 20 B | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 17.01 | -0.09 % | $ 179 M | ||
|
Agilent Technologies
A
|
161 | $ 117.69 | 0.14 % | $ 35.8 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 20.94 | 1.16 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.64 | 3.14 % | $ 2.18 M | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 24.75 | 0.61 % | $ 687 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
50.4 | - | - | $ 12.3 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.73 | -1.97 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
102 | $ 8.89 | 0.34 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Natera
NTRA
|
81.5 | $ 215.09 | 4.02 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 14.92 | 0.13 % | $ 451 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.07 | 9.17 % | $ 360 M | ||
|
Guardant Health
GH
|
128 | $ 92.25 | 3.05 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 124.13 | 2.32 % | $ 10.2 B | ||
|
Illumina
ILMN
|
198 | $ 142.58 | 2.52 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
96 | - | - | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 472.95 | 1.33 % | $ 178 B | ||
|
Biomerica
BMRA
|
204 | $ 2.21 | 1.14 % | $ 5.08 M | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.6 | 0.42 % | $ 61.9 M | ||
|
Lantheus Holdings
LNTH
|
121 | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 256.94 | -0.08 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 59.53 | 4.99 % | $ 3.56 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.18 | -0.97 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
834 | $ 349.53 | 1.98 % | $ 20.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 189.13 | -0.9 % | $ 21 B |